Brief: Relay Therapeutics Q2 Net Income USD -92.212 Million
06/08/2024 21:06
Aug 06 (Reuters) - Relay Therapeutics Q2 operating expenses USD 100.757 million. * Q2 operating income USD -100.757 million * Q2 basic EPS USD -0.69
Recent news on Relay Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Moderna, Kontoor Brands, Ralph Lauren
U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Relay Therapeutics gains after $275 mln equity raise
Brief: Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock